NEA Management Company, LLC
Q2 2014 13F-HR Holdings
Net value change ($000)
+94,531
(4.6%)
New positions
3
Sold out positions
0
Turnover %
10.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| OPOWER INC | 169,599 | NEW |
| TRIVASCULAR TECHNOLOGIES INC | 61,427 | NEW |
| Epizyme, Inc. | 53,825 | 36.7% |
| AVIDITY BIOSCIENCES INC | 45,297 | 124.2% |
| SUPN | 20,342 | 21.4% |
| T | 16,063 | 5.5% |
| INTERMUNE INC | 14,322 | 31.9% |
| FOLD | 7,179 | 61.3% |
| FUSION-IO INC | 5,490 | 7.4% |
| NKTR | 1,278 | 5.8% |
Top Reduces (Value $000, Stocks/ETFs)
| CBIO | -67,744 | -48.4% |
| GRPN | -66,309 | -15.6% |
| Clovis Oncology, Inc. | -63,514 | -40.2% |
| CVENT INC | -42,333 | -19.5% |
| Millennial Media Inc. | -15,873 | -27.9% |
| HYPERION THERAPEUTICS INC | -12,185 | -16.4% |
| TREVENA INC | -8,424 | -28.1% |
| CHANNELADVISOR CORP | -6,336 | -30.2% |
| ZHONE TECHNOLOGIES INC NEW | -5,355 | -26.5% |
| ALIMERA SCIENCES INC | -4,309 | -24.2% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|